PreImplantation Factor Reduces Graft-versus-Host Disease by Regulating Immune Response and Lowering Oxidative Stress (Murine Model)

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 4, 2013, Pages 519-528

  Azar, Yehudith ^a   Shainer, Reut ^a   Almogi Hazan, Osnat ^a   Bringer, Rachel ^a   Compton, Susan R ^b   Paidas, Michael J ^b   Barnea, Eytan R ^c,d,e   Or, Reuven ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Society for the Investigation of Early Pregnancy   (United States)

^d BioIncept LLC   (United States)

^e RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Embryo derived therapy; Graft versus leukemia; Immune regulation; Mismatch; Transplant acceptance

Indexed keywords

GAMMA INTERFERON; IMMUNOLOGIC AGENT; INTERLEUKIN 17; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PROTEIN; PROTEIN PREIMPLANTATION FACTOR; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B CELL LEUKEMIA; BONE MARROW; CELL PROLIFERATION; CONTROLLED STUDY; DERMATITIS; FEMALE; GENE EXPRESSION; GRAFT VERSUS LEUKEMIA EFFECT; HEPATITIS; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ULCER; LOW DRUG DOSE; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; SPLEEN CELL; SURVIVAL;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; DENDRITIC CELLS; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; IMMUNE TOLERANCE; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PEPTIDES; SKIN; SPLEEN; SURVIVAL ANALYSIS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84875528285     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.12.011     Document Type: Article

References (39)

1. Butturini A., Gale R.P. Allogeneic bone marrow transplantation for leukemia. Curr Opin Hematol 1994, 1:402-405.
2. Truitt R.L., Johnson B.D. Principles of graft-vs-leukemia reactivity. Biol Blood Marrow Transplant 1995, 1:61-68.
3. Shlomchik W.D. Graft-versus-host disease. Nat Rev Immunol 2007, 7:340-352.
4. Ratajczak P., Janin A., Peffault de Latour R., et al. Th17/Treg ratio in human graft-versus-host disease. Blood 2010, 116:1165-1171.
5. Yu Y., Wang D., Liu C., et al. Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice. Blood 2011, 118:5011-5020.
6. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
7. Fowler D.H. Shared biology of GVHD and GVT effects: potential methods of separation. Crit Rev Oncol Hematol 2006, 57:225-244.
8. Messina C., Faraci M., de Fazio V., et al. Prevention and treatment of acute GvHD. Bone Marrow Transplant 2008, 41(Suppl 2):S65-S70.
9. Ledee N., Dubanchet S., Oger P., et al. Uterine receptivity and cytokines: new concepts and new applications. Gynecol Obstet Invest 2007, 64:138-143.
10. Gonen-Gross T., Goldman-Wohl D., Huppertz B., et al. Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell-specific expression at the fetal-maternal interface. PLoS ONE 2010, 5:e8941.
11. Barnea E.R., Aboagye-Mathiesen G., Hatch W.C., et al. Pregnancy derived compounds that control proliferation. Cancer and Pregnancy 2001, 277-287. Springer-Verlag, London. E.R. Barnea, E. Jauniaux, P.E. Schwartz (Eds.).
12. Sharma S., Murphy S.P., Barnea E.R. Genes regulating implantation and fetal development: a focus on mouse knockout models. Front Biosci 2006, 11:2123-2137.
13. Barnea E.R. Signaling between embryo and mother in early pregnancy: basis for development of tolerance. Recurrent Pregnancy Loss 2007, 15-21. Taylor & Francis, London. H.J.A. Carp (Ed.).
14. Guleria I., Sayegh M.H. Maternal acceptance of the fetus: true human tolerance. J Immunol 2007, 178:3345-3351.
15. Barnea E.R., Simon J., Levine S.P., et al. Progress in characterization of pre-implantation factor in embryo cultures and in vivo. Am J Reprod Immunol 1999, 42:95-99.
16. Barnea E.R. Insight into early pregnancy events: the emerging role of the embryo. Am J Reprod Immunol 2004, 51:319-322.
17. Than N.G., Paidas M.J., Mizutani S., et al. Embryo-placento-maternal interaction and biomarkers: from diagnosis to therapy-a workshop report. Placenta 2007, 28(Suppl A):S107-S110.
18. Stamatkin C.W., Roussev R.G., Stout M., et al. PreImplantation factor negates embryo toxicity and promotes embryo development in culture. Reprod Biomed Online 2011, 23(4):517-524.
19. Stamatkin C.W., Roussev R.G., Stout M., et al. PreImplantation factor correlates with early mammalian embryo development-bovine and murine models. Reprod Biol Endocrinol 2011, 9:63.
20. Barnea E.R. Applying embryo-derived immune tolerance to the treatment of immune disorders. Ann N Y Acad Sci 2007, 1110:602-618.
21. Paidas M.J., Krikun G., Huang S.J., et al. A genomic and proteomic investigation of the impact of preimplantation factor on human decidual cells. Am J Obstet Gynecol 2010, 202:e451-e458.
22. Barnea E.R., Kirk D., Paidas M.J. PreImplantation factor (PIF) promoting role in embryo implantation: increases endometrial Integrin-α2β3, amphiregulin and epiregulin while reducing betacellulin expression via MAPK in decidua. Reprod Biol Endocrinol 2012, 10:50.
23. Duzyj C.M., Barnea E.R., Li M., et al. PreImplantation factor promotes first trimester trophoblast invasion. Am J Obstet Gynecol 2010, 203:e401-e404.
24. Barnea E.R., Kirk D., Ramu S., et al. PreImplantation factor (PIF) orchestrates systemic antiinflammatory response by immune cells: effect on peripheral blood mononuclear cells. Am J Obstet Gynecol 2012, 207:313.e1-313.e11.
25. Roussev R., Dons'koi B., Stamatkin C., et al. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy. Reprod Biomed Online 2013, 26:79-87.
26. Weiss L., Or R., Jones R.C., et al. Preimplantation factor reverses neuroinflammation while promoting neural repair in EAE model. J Neurol Sci 2012, 312:146-157.
27. Paidas M.J., Annunziato J., Romano M., et al. Pregnancy and multiple sclerosis (MS): a beneficial association. Possible therapeutic application of embryo-specific pre-implantation factor (PIF). Am J Reprod Immunol 2012, 68:456-464.
28. Weiss L., Bernstein S., Jones R., et al. Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice. Endocrine 2011, 40:41-54.
29. Samuel S., Azar Y., Corchia N., et al. Improved immune function with donor B-cell infusion after semi-allogeneic bone marrow transplantation in mice. Arch Med Res 2008, 39:61-68.
30. Panigrahi S., Morecki S., Yacovlev E., et al. A novel approach for prevention of lethal GVHD by selective elimination of alloreactive donor lymphocytes prior to stem cell transplantation. Exp Hematol 2004, 32:756-764.
31. Lutz M.B., Kukutsch N., Ogilvie A.L., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999, 223:77-92.
32. Tomita M., Okuyama T., Hidaka K. Changes in mRNAs of inducible nitric oxide synthase and interleukin-1 beta in the liver, kidney and lung tissues of rats acutely exposed to paraquat. Leg Med 1999, 127-134.
33. Yi T., Li X., Yao S., et al. Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients. J Immunol 2011, 186:2739-2749.
34. Barnea E.R. Embryo maternal dialogue: from pregnancy recognition to proliferation control. Early Pregnancy 2001, 5:65-66.
35. Bettelli E., Carrier Y., Gao W., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
36. Sanz-Cameno P., Medina J., Garcia-Buey L., et al. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 2002, 37:723-729.
37. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 2011, 26(Suppl 1):173-179.
38. Flanagan D.M., Jennings C.D., Goes S.W., et al. Nitric oxide participates in the intestinal pathology associated with murine syngeneic graft-versus-host disease. J Leukocyte Biol 2002, 72:762-768.
39. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003, 9:1144-1150.